Vitamin Shoppe's (VSI -8%) management is taking "a more cautious view on the year" after saying variability in YTD sales performance and weaker than expected sales in April should translate to comps growth in the "low-to-mid single digits." That's a downward revision from previous guidance. Comps growth was 4.5% in Q1, down markedly from 9.6% in Q1 2012 and off by 0.7% sequentially. VSI does note on the call however, that 2012 Q1 comps benefited from "higher whey protein inflation." (PR, transcript)
Check out Seeking Alpha’s new New Earnings Center
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Jan 2, 2015)
at Nasdaq.com (Dec 4, 2014)
at CNBC.com (Nov 7, 2014)
at CNBC.com (Nov 4, 2014)
at CNBC.com (Oct 28, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs